Litium: Beat on sales and EBITDA - ABG
Sales +10%, EBITDA +13% vs. ABGSCe
New ARR definition more comparable with peers
Cost base discipline drives margins
Q1'24 report
Litium reported an ARR of SEK 71.1m (based on a new definition), net sales of SEK 17.7m (+10% vs. ABGSCe 16.1m) and EBITDA of SEK 4.0m (+13% vs. ABGSCe 3.5m). Due to the new ARR definition, our unrevised ARR estimate is obsolete. However, the restated historical ARR values show that sequential growth is still intact, and that is of course positive. Moreover, the company beat slightly on EBITDA again, suggesting continued cost discipline.
Länk till analysen i sin helhet: https://cr.abgsc.com/foretag/Litium/Equity-research/2024/4/litium---beat-on-sales-and-ebitda/